Page 3 - Brian Mckelligon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Akoya Biosciences opens another Marlborough facility to meet rising demand

Akoya Biosciences opens another Marlborough facility to meet rising demand
wbjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wbjournal.com Daily Mail and Mail on Sunday newspapers.

Brian mckelligonAkoya biosciencesManufacturing centerPhio pharmaceuticalsMarlborough based akoya biosciencesCambridge based moderna

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

KR-HT5 is based on Akoya’s PhenoImager® HT PlatformMARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 Akoya Biosciences, Inc. , The Spatial Biology Company®, and Shanghai KR Pharmtech, a.

Akoya biosciencesBrian mckelligonRui zhangAkoya biosciencePriyam shahAkoya phenoimagerSpatial biology companyMedicine technology researchExchange commissionChina national medical products administrationAkoya biosciences incSpatial biologyNational medical products administrationMultispectral imagingNext generation pathologyFinancial condition

Akoya Biosciences, Inc (NASDAQ:AKYA) Given Consensus Recommendation of Moderate Buy by Brokerages

Akoya Biosciences, Inc (NASDAQ:AKYA) Given Consensus Recommendation of Moderate Buy by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAkoya biosciencesBrian mckelligonAsia pacificSchonfeld strategic advisorsAkoya biosciences incCanaccord genuity groupJpmorgan chase coSecurities exchange commissionPolar capital holdings plcKent lake capitalYork mellon corpGet free reportMarketbeat ratingsExchange commissionNew york mellon corp

Kent Lake Capital LLC Sells 629,686 Shares of Akoya Biosciences, Inc (NASDAQ:AKYA)

Kent Lake Capital LLC lowered its holdings in shares of Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) by 84.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 116,835 shares of the company’s stock after selling 629,686 shares during the period. Kent Lake Capital LLC’s holdings in Akoya Biosciences were worth $570,000 at the […]

United statesBrian mckelligonAkoya biosciencesAsia pacificBlackrock incUnisuper management pty ltdKennedy capital managementKent lake capitalCanaccord genuity groupAkoya biosciences incPeddock capital advisorsJpmorgan chase coHoldings channelFree reportLake capitalWater life science advisors

Akoya Biosciences, Inc (NASDAQ:AKYA) Receives $9 07 Consensus Target Price from Brokerages

Akoya Biosciences, Inc (NASDAQ:AKYA) Receives $9 07 Consensus Target Price from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAkoya biosciencesBrian mckelligonAsia pacificSecurities exchange commissionCanaccord genuity groupLazard asset managementJpmorgan chase coAkoya biosciences incCitigroup incBarclays plcNisa investment advisorsGet free reportMarketbeat ratingsExchange commissionAsset management